The new application notes for our EndoLow® Peptides are now available.

A few months ago, we expanded the product family of Hispanagar with the new EndoLow Peptones® some peptones with low levels of endotoxins without the need for ultrafiltration, developed in the R&D department of Biotecnica.

The EndoLow Peptones® are a new generation of peptones formulated to meet the needs of the biopharmaceutical industry in its drug, vaccine, and other diagnostic product production processes. The EndoLow Peptones ® are an excellent source of peptides, vitamins, and carbohydrates that enhance cell growth in culture media. 

The results obtained in the Application Notes have shown that the EndoLow Peptones® stand out above their competitors, and demonstrate that it is a revolutionary product for the industry.  

 The new application notes show the results of beef peptone and casein peptone.

The first study shows that the beef peptone EndoLow® has better cell growth and cell viability, improving the results of ultrafiltrated beef hydrolysates and non ultrafiltrated from different competitors.

In the second study, the casein peptone EndoLow® also has better cell growth and cell viability compared to casein hydrolysates from different competitors. 

Contact our sales team to receive the application notes and you will be able to check in detail both studies and the results obtained by the EndoLow® peptones compared to other peptones available on the market.